102 related articles for article (PubMed ID: 16617391)
1. The brain scintiscan with iodine-123-ioflupane to diagnose early Parkinson's disease; seven months follow up. First results in Bulgaria.
Piperkova E; Georgiev R; Daskalov M; Stamenova P; Katerinski K; Beeva M; Orozova M; Dimitrova M
Hell J Nucl Med; 2006; 9(1):31-5. PubMed ID: 16617391
[TBL] [Abstract][Full Text] [Related]
2. [Findings from molecular imaging with SPET camera and 123I-ioflupane in the differential diagnosis of Parkinsonism and essential tremor].
Gerasimou G; Tsolaki M; Bostanjopoulou S; Liaros G; Papanastasiou E; Balaris V; Katsarou Z; Fotiou F; Dedousi E; Baloyannis S; Milonas I
Hell J Nucl Med; 2005; 8(2):81-5. PubMed ID: 16142248
[TBL] [Abstract][Full Text] [Related]
3. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
Jauković L; Ilić TV; Dopudja M; Ajdinović B
Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
[TBL] [Abstract][Full Text] [Related]
4. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK
J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1.
Tzen KY; Lu CS; Yen TC; Wey SP; Ting G
J Nucl Med; 2001 Mar; 42(3):408-13. PubMed ID: 11337515
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease.
Huang WS; Lee MS; Lin JC; Chen CY; Yang YW; Lin SZ; Wey SP
Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):155-61. PubMed ID: 15129696
[TBL] [Abstract][Full Text] [Related]
7. SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson's disease?
Gerasimou G; Costa DC; Papanastasiou E; Bostanjiopoulou S; Arnaoutoglou M; Moralidis E; Aggelopoulou T; Gotzamani-Psarrakou A
Ann Nucl Med; 2012 May; 26(4):337-44. PubMed ID: 22382608
[TBL] [Abstract][Full Text] [Related]
8. Discrimination between parkinsonian syndrome and essential tremor using artificial neural network classification of quantified DaTSCAN data.
Hamilton D; List A; Butler T; Hogg S; Cawley M
Nucl Med Commun; 2006 Dec; 27(12):939-44. PubMed ID: 17088678
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson's disease.
Okada Y; Shiraishi M; Nakamura H; Maki F; Sasaki N; Hasegawa Y; Sasaki O; Nakashima Y
Nucl Med Commun; 2018 Nov; 39(11):983-988. PubMed ID: 30180045
[TBL] [Abstract][Full Text] [Related]
10. Comparison between visual assessment of dopaminergic degeneration pattern and semi-quantitative ratio calculations in patients with Parkinson's disease and Atypical Parkinsonian syndromes using DaTSCAN® SPECT.
Davidsson A; Georgiopoulos C; Dizdar N; Granerus G; Zachrisson H
Ann Nucl Med; 2014 Nov; 28(9):851-9. PubMed ID: 24997753
[TBL] [Abstract][Full Text] [Related]
11. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
[TBL] [Abstract][Full Text] [Related]
12. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
13. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 99mTc-TRODAT-1 SPECT and 18 F-AV-133 PET imaging in healthy controls and Parkinson's disease patients.
Hsiao IT; Weng YH; Lin WY; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lu CS; Lin KJ
Nucl Med Biol; 2014 Apr; 41(4):322-9. PubMed ID: 24503330
[TBL] [Abstract][Full Text] [Related]
15. [
Ahmed A; Huang J; Chen K; Zubeldia JM; Booij J; Vijayakumar V
J Neurol Sci; 2018 Dec; 395():159-163. PubMed ID: 30336391
[TBL] [Abstract][Full Text] [Related]
16. 123I-FP-CIT in progressive supranuclear palsy and in Parkinson's disease: a SPECT semiquantitative study.
Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
Nucl Med Commun; 2006 Apr; 27(4):381-6. PubMed ID: 16531926
[TBL] [Abstract][Full Text] [Related]
17. A visual and semi-quantitative assessment of (99m)Tc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules.
Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):143-50. PubMed ID: 15968601
[TBL] [Abstract][Full Text] [Related]
18. Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease.
Hwang WJ; Yao WJ; Wey SP; Ting G
J Nucl Med; 2004 Feb; 45(2):207-13. PubMed ID: 14960637
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS
J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G
Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
